Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Tolimidone by Melior Pharmaceuticals I for Type 2 Diabetes: Likelihood of Approval
Tolimidone is under clinical development by Melior Pharmaceuticals I and currently in Phase II for Type 2 Diabetes. According to...